Ovarian cancer is an increasingly common gynecological malignancy. According to the American Cancer Society ACS, the average risk of ovarian cancer in women is 1 in 78.

Malignant cancer is a disease with rapid proliferation of abnormal cell lines, leading to aggressive invasion and metastasis to surrounding tissues. When performing tests to assess cancer status, elevated levels of cancer markers can cause anxiety in patients undergoing testing.

Cancer has always been one of the leading causes of death in the world. Periodic screening with cancer tests plays an important role in early detection and appropriate treatment orientation. The cancer marker test index is also an effective tool to help increase the definite diagnosis of cancer-positive cases.